Push To Create Ultra-Rare Orphan Drug Designation Finds Resistance At US FDA

 
• By Derrick Gingery
  
roadblock
Without FDA support, passing legislation to create ultra-orphan incentives will become more difficult. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Pink Sheet